IN-VITRO AND IN-VIVO MODULATION OF ALPHA-GLUCOCORTICOID-RECEPTOR AND BETA-GLUCOCORTICOID-RECEPTOR MESSENGER-RNA IN HUMAN BRONCHIAL EPITHELIUM

Citation
Sh. Korn et al., IN-VITRO AND IN-VIVO MODULATION OF ALPHA-GLUCOCORTICOID-RECEPTOR AND BETA-GLUCOCORTICOID-RECEPTOR MESSENGER-RNA IN HUMAN BRONCHIAL EPITHELIUM, American journal of respiratory and critical care medicine, 155(3), 1997, pp. 1117-1122
Citations number
35
Categorie Soggetti
Emergency Medicine & Critical Care","Respiratory System
ISSN journal
1073449X
Volume
155
Issue
3
Year of publication
1997
Pages
1117 - 1122
Database
ISI
SICI code
1073-449X(1997)155:3<1117:IAIMOA>2.0.ZU;2-B
Abstract
Despite the central role bronchial epithelial cells play in asthmatic reactions, and the widespread use of inhaled corticosteroids in asthma , no information is available on the effect of glucocorticoids on gluc ocorticoid- receptor (GR) gene expression. In this study, the effect o f budesonide on alpha- and beta-GR gene expression in human bronchial epithelial cells was investigated in vitro and in vivo. A bronchial ep ithelial cell line was exposed in vitro to budesonide, and a dose- and time-dependent synchronous downregulation of alpha- and beta-GR mRNA was observed. A 1-h exposure resulted in a reversible and reduced down regulation as compared with continuous exposure. In healthy volunteers (n = 10), no difference on average was present in GR mRNA expression before or after 4 wk of budesonide inhalation in either bronchial epit helial cells or alveolar macrophages. The time between the last inhala tion and sampling of cells ranged from 0.5 to 8 h. However, a signific ant downregulation of alpha-GR mRNA was observed when the time between the last inhalation and sampling of cells was more than 2 h. Normaliz ation of the downregulation of GR mRNA expression in bronchial epithel ial cells is explained by the pharmacokinetics of inhaled budesonide i n the human lung.